Arcadia Biosciences | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 1.302 M

Revenue: As of FY2025 Q3, the actual value is USD 1.302 M, missing the estimate of USD 1.9 M.

Zola Coconut Water: Revenues were flat year-over-year in the third quarter of 2025 but increased 26% year-to-date, offsetting $700,000 in GLA sales from 2024 that did not occur in 2025.
Product Revenue: For the three months ended September 30, 2025, product revenue was $1,302 thousand, compared to $1,537 thousand for the same period in 2024. For the nine months ended September 30, 2025, product revenue was $3,957 thousand, compared to $3,829 thousand in 2024.

Gross Profit Margins: Exceeded 30% for the eleventh consecutive quarter.
Total Revenues: Decreased by $235,000, or 15%, during the third quarter of 2025 compared to the same period in 2024.
Total Operating Expenses: Decreased by $843,000, or 26%, during the third quarter of 2025 compared to the same period in 2024.
Loss from Continuing Operations: Improved by $608,000, or 35%, during the third quarter of 2025 compared to the same period in 2024.
Net Income (Loss): For the three months ended September 30, 2025, net income from continuing operations was $856 thousand, compared to a net loss of - $1,182 thousand for the same period in 2024. For the nine months ended September 30, 2025, net loss from continuing operations was - $1,003 thousand, compared to - $280 thousand in 2024.
Operating Expenses: Total operating expenses for the three months ended September 30, 2025, were $2,454 thousand, compared to $3,297 thousand for the same period in 2024. For the nine months ended September 30, 2025, total operating expenses were $5,082 thousand, compared to $5,198 thousand in 2024.

Operating Cash Flow: Net cash used in operating activities for the nine months ended September 30, 2025, was - $3,878 thousand, compared to - $7,418 thousand for the same period in 2024.
Investing Cash Flow: Net cash provided by investing activities for the nine months ended September 30, 2025, was $750 thousand, compared to $4,827 thousand in 2024.
Financing Cash Flow: Net cash provided by financing activities for the nine months ended September 30, 2025, was $6 thousand, compared to $9 thousand in 2024.
Cash Balance: Arcadia’s cash balance declined by only $257,000 to $1.1 million.

Above Food Ingredients, Inc. Stock: Arcadia continues to own 2.7 million shares of Above Food Ingredients Inc. stock as partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheat assets.
Fair Value of Above Food Ingredients, Inc. Common Stock Received: The fair value of Above Food Ingredients, Inc. common stock received was $3,067 thousand for the nine months ended September 30, 2025.

The pending business combination with Roosevelt Resources is still in progress, but uncertainty exists regarding the timing due to several factors including the ongoing federal government shutdown. Arcadia is monitoring events closely, but the shutdown is a situation outside of their control.